title: Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.
abstract: BACKGROUND
  Neuronal nicotinic acetylcholine receptors (nAChRs) play a modulatory role in cognition, and zebrafish provide a preclinical model to study learning and memory.
  
  
  OBJECTIVE
  We investigated the effect of nicotine (NIC) and some new cytisine-derived partial agonists (CC4 and CC26) on spatial memory in zebrafish using a rapid assay on T-maze task. The role of α4/α6β2 and the α7 nAChRs in NIC-induced memory enhancement was evaluated using selective nAChR antagonists.
  
  
  RESULTS
  Low and high doses of NIC, cytisine (CYT), CC4 and CC26 respectively improved and worsened the mean running time, showing an inverted U dose-response function. The effective dose (ED50) (×10⁻⁵ mg/kg) was 0.4 for CC4, 4.5 for CYT, 140 for NIC and 200 for CC26. NIC-induced cognitive enhancement was reduced by the selective nAChR subtype antagonists: methyllycaconitine (MLA) for α7, α-conotoxin (MII) for α6β2, dihydro-β-erythroidine (DhβE) for α4β2, the nonselective antagonist mecamylamine (MEC) and the muscarinic antagonist scopolamine (SCOP), with DhβE being more active than MLA or MII. All the partial agonists blocked the cognitive enhancement. The improvement with the maximal active dose of each partial agonist was blocked by low doses of DhβE (0.001 mg/kg) and MII (0.01 mg/kg). MLA reduced the effects of CC26 and CC4 at doses of 0.01 and 1 mg/kg, respectively, but did not antagonize CYT-induced memory improvement at any of the tested dose. No change in swimming activity was observed.
  
  
  CONCLUSIONS
  Our findings demonstrate that zebrafish make a useful model for the rapid screening of the effect of new α4β2 nAChR compounds on spatial memory.
authors: Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Milan, Italy.
authors: Daniela
authors: D
authors: Braida
authors: Luisa
authors: L
authors: Ponzoni
authors: Roberta
authors: R
authors: Martucci
authors: Fabio
authors: F
authors: Sparatore
authors: Cecilia
authors: C
authors: Gotti
authors: Mariaelvina
authors: M
authors: Sala
mesh_terms: D000157:Aconitine / Q000031:analogs & derivatives / Q000494:pharmacology; D000470:Alkaloids / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D001392:Azocines / Q000737:chemistry / Q000494:pharmacology; D018678:Cholinergic Agents / Q000494:pharmacology*; D020916:Conotoxins / Q000494:pharmacology; D004079:Dihydro-beta-Erythroidine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D018782:Maze Learning / Q000187:drug effects / Q000502:physiology*; D008464:Mecamylamine / Q000494:pharmacology; D008568:Memory / Q000187:drug effects / Q000502:physiology*; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009538:Nicotine / Q000494:pharmacology; D018722:Nicotinic Agonists / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000737:chemistry / Q000494:pharmacology; D011807:Quinolizines / Q000737:chemistry / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000378:metabolism*; D012601:Scopolamine / Q000494:pharmacology; D013550:Swimming; D015027:Zebrafish / Q000502:physiology*; D029961:Zebrafish Proteins / Q000378:metabolism; D000093843:Quinolizidine Alkaloids
chemical_list: D000157:Aconitine; D000470:Alkaloids; D001392:Azocines; D018678:Cholinergic Agents; D020916:Conotoxins; D004079:Dihydro-beta-Erythroidine; D008464:Mecamylamine; D018727:Muscarinic Antagonists; D009538:Nicotine; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D011807:Quinolizines; D011978:Receptors, Nicotinic; D012601:Scopolamine; D029961:Zebrafish Proteins; C054634:methyllycaconitine; C004712:cytisine; D000093843:Quinolizidine Alkaloids